Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Safety and Efficacy of CAT-354

This study has been completed.
Information provided by (Responsible Party):
MedImmune LLC Identifier:
First received: April 1, 2009
Last updated: August 29, 2012
Last verified: August 2012